Show Posts

This section allows you to view all posts made by this member. Note that you can only see posts made in areas you currently have access to.

Messages - TalithaCumi

Pages: [1] 2 3 ... 5
Others / Are Terminal Diseases Truly Death Sentence?
« on: May 13, 2019, 09:59:10 AM »
What are terminal diseases? A terminal disease or illness has been said to be a disease or condition which can't be cured and is likely to lead to someone's death. Examples of terminal disease are HIV, Cancer, Arthritis, Diabetes, Epilepsy, Hypertension, etc.

Humanity has come so far in terms of technological advancements and medical break throughs. We've invented machines that we use to swim in Oceans like fishes and we now have machines that help us fly in the sky better than birds. Man has landed on Moon and our crafts are landing/exploring other planets such as Mars. We've produced better varieties plants and animals for massive food yield than the natural. GMO is daily "blessing" humanity with better fast yielding varieties of food crops and animal products.

Our medical technology has advanced so much that we are now fully able to clone and produce new humans like our selves without taking the natural procreation path. With all this awesome advancements in our World, is it not stranger than fiction that the World Health Authority, that is saddled with responsibility of seeing to it that all men are hale and healthy, says they are yet to find cure to many medical problems of man.

I'll share some verifiable revelations here, but I want us all to be involved. This is a discussion thread for us all. Do you think these diseases are truly incurable? If no, post links and documents to enlighten our people better. Keep it coming:

Herbal Cures / HIV Real Permanent Cure
« on: May 13, 2019, 09:56:44 AM »
After discovering revelations that we shall be sharing here, I know that you too will soon wonder and ask why didnt they legalize theese cures? Who is interested in keeping the vast majority of humanity sick? If you already know that all terminal diseases actually have permanent cure, don't let anyone you know suffer or die in silence. For permanent Cure for Diabetes, Cancer, Arthritis, HIV, Hypertension, Epilepsy, Chronic Fatigue Syndrome, Hidradenitis Supurativa, etc. Contact me:

If you've not yet known or believe that HIV and others have permanent cure, watch these videos of people daily getting permanently cured of HIV after taking the herbal medicine for just 15 days. Then come back here and comment what you think:

3. Low T: Opioid pain killers can also be testosterone killers. Opioids disrupt the natural regulation of the body's endocrine system, including interfering with how the hypothalamus and pituitary glands in the brain regulate hormone production in the gonads. The stronger the pain killer, the more testosterone production is likely to get suppressed, leading to problems like diminished libido, infertility, depression, and fatigue.
4. Opioids Can Be Fattening: Long-term opioid use has been linked to weight gain. This might be explained by studies that have found that when patients use opioids they prefer to get more of their calories from sugary foods and less from whole grains, fruits, and vegetables. As an example, chronic methadone use is associated with significant increases in body mass index and obesity rates.
5. Disrupts the gut flora: Hundreds of different types of bacterial species inhabit the human intestines, and the balance of power between these various microorganisms is now thought to have a big impact on how we feel and what types of diseases we get. Besides what we eat, the gut's flora can be influenced by other factors, including medications. While most patients who take opioid pain killers are well-aware of their constipating side effect, many don't consider the impact opioids can have on the gut flora. For example, one study found that morphine use led to an over-abundance of the gut bacteria Pseudomonas aeruginosa, leading to disruptions in the intestinal lining, and alterations in immune cell activity.

6. Immune System Suppression: Studies done on both humans and animals have shown that commonly used opioid-based pain medications can also inhibit the function of immune cells. In fact, researchers have found the presence of opioid receptors on immune cells giving them the potential to have a direct effect. This raises concerns for chronic users being at a greater risk for developing a whole host of infections.
While addiction remains a dangerous problem for a certain subset of the population on daily opioid pain medication regimens, there seems to be a whole lot more to be concerned about for everyone else. When a pill can have these types of problematic effects on the immune system, endocrine system, gastrointestinal system, and nervous system all at the same time plus lack evidence of sustainable efficacy, then it is time to take a time out and second guess what the pharmaceutical companies are feeding you.

Perhaps no health problem in America is in bigger need of an infusion of quality care right now than the treatment of pain. One form of treatment that has been under the microscope as of late is the prescribing of opioid-based pain killers, with concerns largely being fueled by the rise in accidental deaths and other addiction-associated problems, including a sharp uptick in heroin use.
We spend an average of $3.6 billion a year on prescription narcotic pain killers while consuming 80 percent of the global supply, including 99 percent of all manufactured hydrocodone. In other words, we seem to have a corner on a very lucrative market.
While regulatory agencies are now putting a heavy emphasis on improving safe practices at the level of the doctor office and pharmacy, this still does little to bring value to the millions of pain patients who continue to remain dependent on opioid-based pain killers. But while doctors and pharmacists are feeling pressured to put more of their time and energy into tighter regulation and oversight of prescription pain killers, this emphasis on more rigorous monitoring is more of a safety measure as opposed to a tool to provide higher quality care with better outcomes.
When it comes to treating pain with opioids, there is a lot for patients and their doctors to consider before starting treatment that unfortunately often gets overlooked. In fact research over the last decade has raised both efficacy and safety concerns about opioid pain killers that seem to be buried in science journals hidden far far away from the exam rooms where they should be getting talked about. Here are six red flag concerns about long-term opioid use that you should be aware but I'm guessing you probably haven't heard of:
1. Scientific Support Is MIA: By the end of the 20th century, it had become readily apparent that the newer opioid-based pain medications that were coming out could improve doctors' and nurses' ability to manage acute pain problems like post-surgical pain and horrific burn injuries, and that they could also play a helpful role in providing comfort care for painful end of life conditions like terminal cancer or AIDS. Within a short period of time, the pharmaceutical industry helped convince physicians, patients, and politicians that the extended use of these same types of medications would be just as effective for treating painful chronic conditions like back pain, fibromyalgia, and arthritis. Opioid management soon became a mainstay for chronic pain treatment based on empirical assumptions of how it worked in the acute care setting, but now, some three decades later, there is still a real void of scientific evidence to be found showing that long-term opioid therapy is effective in the management of chronic pain conditions. One of the common deficiencies of many pain studies is that they only plot results over a short period of time, as in weeks or months, when we really need to know what the results will look like for many years to come. The unfortunate reality is that no scientifically sound study (randomized controlled) has ever really come out to support the use of opioids beyond about three months.

2. Can Increase the Hurt: Imagine going on a new blood pressure medication for hypertension only to find out that after a while it will make your blood pressure shoot up again! In some cases, the continued use of opioid pain killers can have the same effect on your pain. This bizarre phenomenon is known as opioid-induced hyperalgesia (OIH). This paradoxical effect means that the body's nervous system becomes more sensitive to experiencing pain, and everything from a stubbed toe to a paper cut will likely hurt more. The mechanism behind how exposure to opioids leads to OIH is still not well-understood but is a hot area of research, particularly for those hoping to discover a new block-buster pain pill.

GalaxySwitchPine knockoffs that have been flooding China.
Since then, the company made the heroic decision to investigate themselves and found that the entire bribe thing was orchestrated by four senior executives who acted alone, against company guidelines.

But in light of GSK's vehement "It was all a few loose cannons" defense, you have to wonder what kind of illicit stuff Pfizer was really into. Because when Pfizer was caught bribing medical professionals in Bulgaria, Croatia, the Czech Republic, Italy, Kazakhstan, Russia, China, and Serbia to get them to prescribe more of the company's drugs, they quickly admitted their guilt and agreed to pay $60 million in fines.

We assume that means the bribery had netted them $60 billion.
But really, we're surprised they didn't go with "Literally everyone does this" as their defense. When the drug giant Eli Lilly bribed Chinese officials and doctors, they had to throw in some expensive jewelry and spa treatments to secure their business interests abroad.

So what did they get for their bribes? Well, it involves straight up paying doctors and hospitals to prescribe their drugs instead of their competitors'. As in, your doctor prescribes you a pill not because it's the best one for your condition, but because the drug company bought him a new motorcycle. Wait -- it's actually sadder than that. Pfizer China allegedly "created 'point programs' that could be redeemed for gifts like cellphones and tea sets based on how many prescriptions the physicians wrote."

but not a moment longer than they have to. This leads to super condensed sales pitches, and if something's going to get cut, it'll be the downsides. A far larger part of the problem, however, is that despite the law being pretty clear on these points, there's practically no oversight or enforcement of it whatsoever.

Meanwhile, the drug companies are spending billions on TV ads telling patients to demand these drugs from their physician. So, the doctors are getting pressured from all sides. But really, why should they worry about it when they just read that informative journal article talking about how safe the drug is?
And if we're making it sound like there are paid shills everywhere, well, that's because drug companies are ...

 Planting Shills Everywhere

You can't read any product label nowadays without discovering that it's been endorsed by the American Society of Whatever, recommended by the National Center for Stuff, or enjoyed by the International Institute of Things.

As it turns out, most of these groups are pharmaceutical industry shills recommending medication based not on rigorous research, but rather the name that appears on their checks. Take the American Acne and Rosacea Society, for example. It's a theoretically impartial organization that's factually funded almost entirely by manufacturers of acne medication like Galderma, which has 13 of the 15 AARS experts on its payroll. So when AARS recommended a treatment for acne, it was no surprise that they went with Galderma's $2,500-a-year plan, instead of the equally effective $120-a-year generic alternative.

"Anything is possible!"
According to a study from the Journal Sentinel, among 20 clinical guidelines for the top-selling drugs in the U.S. (including Nexium, Lipitor, and Oxycontin), 16 were drafted by doctors with clear ties to drug companies. Case in point: GlaxoSmithKline's asthma medication Advair was America's fifth best-selling drug of 2011, thanks to a recommendation by the National Heart, Lung, and Blood Institute, which might have come about because 12 of the institute's 18 panel members were being paid by GSK.

But it's one thing when a bunch of professionals basically recommend brushing your teeth with dog food just because they're sponsored by Purina. It's a whole other thing when their shilling can kill you.

"When you think about it, what is 'death' really?"
Let's take what drug giant Wyeth did in 2002, after discovering that their hormone therapy drugs for menopause increased risk of breast cancer, heart disease, stroke, and blood clots. The problem was that the drugs Prempro and Premarin were already on the market, so instead of recalling them, the company spent $12 million forming the Council on Hormone Education, 85 percent of whose members were working for Wyeth. They then spent the next six years conducting an online course "educating" thousands of doctors about how totally awesome hormone therapy is, and how all that cancer/stroke business was probably due to something the patients did in their free time.

 Continue Reading Below

And in some cases they can take a, well, more direct approach ...

 Rampant Bribery

It turns out that big drug companies hand out bribes -- extensively, frequently, and usually in foreign countries. For instance, GlaxoSmithKline is currently under investigation for dishing out about $500 million in bribes to Chinese doctors, government officials, hospital administrators, and anyone else who happened to be standing around at bribe o'clock. The payouts were meant to secure the company a bigger market share in the country by, assumingly, getting the government to crack down on the Gal

OK, the actual practice is a little more subtle than the kitten thing. In one real case, drug company Medtronic paid $210 million to dozens of surgeons to sign their names to medical articles that were drafted and edited with the help of Medtronic marketers to advertise the company's bone-growth product Infuse ... the same Infuse that was later linked to cancer and infertility in men, which might have affected any of the million people who were prescribed it. The warnings were always there in the fine print, but the marketers were able to tweak the wording to play up the benefits and brush off the horrifying risks and side effects. The authors who went along with it could later be seen wearing lab coats made of solid gold.

 But even when drug companies go to the effort of conducting genuine scientific studies, oftentimes they simply don't publish the unfavorable results. In one experiment, a number of studies of an antidepressant medication were submitted to a drug regulatory authority, and in the end, only the studies that yielded favorable results were released to the public. Oh, did we forget to mention that the studies were funded by huge pharmaceutical conglomerates? This is why some researchers believe that the vast majority of studies on antidepressants are unreliable at best and completely idiotic at worst.

Personally, we prefer the trial-and-error method.
But what about independent studies that aren't paid for by big businesses? Sure, they exist, but many of the researchers end up getting sued, and the studies are kept from publication by the drug company lawyers. Remember, the companies don't even need to win their suits -- all they need to do is keep bringing the scientists back to court until they run out of money and resort to burning their research notes for warmth.

 Deploying an Army of Lying Sales Representatives

Other than medical journals, the other way for doctors to stay informed about drugs is through sales reps, who visit medical professionals and tell them about the newest pill-magic their company has come up with. Sales representative visits are basically the medical education equivalent of a pizza delivery in a porno, by which we mean that they are quick and convenient and usually end with someone getting fucked. The bad news? That someone is usually us.

"On the plus side, we've got plenty of birth control options for you to use while we do it."
In most countries, drug sales reps are legally required to disclose all relevant information about a drug they are promoting to the doctor, not just the fun stuff. But in the U.S., Canada, and France, it's been found that they only mention serious drug risks 6 percent of the time. Because, you know, they're in sales. Their goal isn't to inform; their goal is to get the doctors to sign on the dotted line -- and your doctor is just as susceptible to slick sales techniques as anybody else.

So what's the risk here? Well, more than half of the drugs whose downsides aren't mentioned carry the most severe warning that can be issued -- we're talking "may cause death" territory here. And that's just for the risks -- things that might go horribly wrong when someone takes the drug. This is not to be confused with side effects, which are things that will almost definitely go horribly right if you take the drug. But again, sales reps won't even mention side effects in 59 percent of the cases.

"When you think about it, what is 'anal bleeding' really?"
Part of the problem is that some hospitals might be greeting over a dozen sales reps a day. The doctors want to listen just long enough to get the merchandise and free samples, but not a


f you go by their portrayal in movies and TV shows, you'd think that huge pharmaceutical corporations make all their money by turning children into zombies and having them steal grandma's heart medication, or whatever the plot of Resident Evil was. But the truth is that Big Pharma (as hippies and crackpots call it) isn't a modern-day Legion of Doom. They're businesses focused on making money, just like every other company out there ... which isn't to say they aren't capable of evil. They totally are. It's just that their evil usually involves less illegal genetic experiments and more down-to-earth jerk moves like ...

 Repackaging Medication to Trick You into Taking It
The name of a drug is a crucial part of its marketing. The antidepressant Prozac, for example, is meant to sound sciency, while the drug Sarafem, which is targeted at women, sounds distinctly feminine. However, the only differences between these supposedly very different drugs are their names and colors: Sarafem is actually just Prozac, because Eli Lilly, the drug company behind both medications, wanted women to take the drug without telling them what it was.

"But it says 'fluoxetine' right on the label. How can you not immediately know what that is?!"
Sarafem was marketed as the cure for an ailment called premenstrual dysphoric disorder -- essentially, all the unpleasantness that goes along with menstruation, plus horrible panic attacks, anxiety, and souped-up mood swings. And we're not saying that Prozac doesn't treat those symptoms; it might (we're not doctors). We just think that tricking people into taking drugs they wouldn't otherwise take is a moral gray area, although it could be forgiven if it was done for noble intentions. Like, say, if women suffering from PMDD really needed to take Prozac but were avoiding it due to its negative association with depression. That, however, is not what happened here.

Prozac was a huge money maker for Eli Lilly, and Sarafem was released only a few months before their patent on Prozac was set to expire. When a drug patent expires, its price drops sharply, as competitors start releasing their own generic versions. But by releasing a new drug identical to Prozac, Eli Lilly managed to extend their patent by a few years, allowing the price of Prozac to remain nice and high.

In 1997, GlaxoSmithKline did something similar when they released the well-known antidepressant Wellbutrin as a pill that helps you quit smoking, but only after rebranding it as Zyban. Again, the science behind the drug might have actually been sound, but it doesn't change the fact that deceiving people into taking mind-altering drugs is something you usually expect to end with James Bond blowing up a skull-shaped island fortress in the middle of the Pacific.

 Flooding the World With Bad Research
So how exactly do doctors know what medication to give you, when new stuff is coming out all the time?
Well, they read medical journals, which are full of studies telling them what's working these days. Unfortunately, pharmaceutical companies know that, so when they roll out a new product that they know occasionally gives patients uncontrollable diarrhea, they first release an overwhelming number of falsified studies that replace the word "diarrhea" with "kittens."

Over the past year we have heard stories of Big Pharma being out to get the growing medical cannabis industry. We wanted to know if there was any truth behind these fears, oft dismissed as conspiracy theories.

We spoke to a pharmaceutical market analyst* to see if the cannabis industry should fear Big Pharma. Here’s what they told us.

*Due to the sensitive nature of their work, their name has been withheld.
Despite its slow entrance to the clinical setting, medical cannabis research has recently seen renewed interest due to a plethora of data now available boasting its efficacious and safe effects in treating various diseases. Presently, it is no secret that Big Pharma is lobbying against the increasingly confident cannabis wave since the conditions that cannabis may be used to treat are highly prevalent, and thus currently very lucrative for Big Pharma.

Big Pharma’s future of ‘blockbuster profits’ are under threat by the pricing cut downs promised by the two US presidential candidates. The US drug market is the largest in the world in terms of profitability, which is greatly aided by the high cost of prescription drugs – on average between 3 to 5 times higher than in the EU. Big Pharma have spent years reaping the rewards from their high price pharmaceuticals until a public firestorm initiated from Martin Shkreli’s 5,000% price hike on toxoplasmosis treatment Daraprim put Big Pharma’s prices right in the spotlight. This is significant, as public awareness of high drug prices fuels enthusiasm for a cheaper, effective option such as cannabis.

The promised beat down on drug prices has now coincided with a surge in public and madical interest in the use of medical cannabis; a potential double hit on Big Pharma’s profitability. Indeed, legalising medical cannabis would significantly impact Big Pharma’s sales growth and US patients, in states where cannabis is legalised, are already turning towards its use against prescription medications.

A new survey conducted by the Centre for Addictions Research of British Colombia found that 87% of surveyed therapeutic cannabis users gave up prescription medications, alcohol, or other drugs in favour of cannabis. Moreover, a study from the University of Georgia examined the costs of Medicare’s prescription drug benefit program in 2013 over 17 states, and found a savings of $165.2 million in prescription costs due to cannabis use. Savings in this manner are likely to rise significantly as cannabis legalisation sweeps over additional countries, targeting an increasing number of disease areas. Hence, it is not overly surprising that Big Pharma is fearful at the present time as these revenues are being bled directly from their profits.

In an age where prescription medications are at an all-time high and patients are becoming the key stakeholders in determining the outcomes of expensive medications, we are now looking more towards the cost-effectiveness of alternatives. Evaluating the cost-effectiveness of drugs is now the established strategy around EU country-specific regulators, such as NICE and G-BA. These healthcare austerity measures are becoming increasingly stringent on the cost-benefit analysis of new agents in comparison to existing technologies. Unfortunately for Big Pharma, this regime has helped keep drug prices much lower in the EU in order for them to be deemed ‘cost-effective’.

Cannabis may prevail here due to its low associated cost, disease versatility, demonstrated efficacy, and improved safety against competitor prescription medications. In this manner, cannabis may acquire a positive cost-effectiveness evaluation in the EU which would create a window of opportunity for its uptake against Big Pharma’s pricier prescription meds in the future. Indeed tides are turning as Canadian cannabis research giant, Tilray, have recently imported the first ever legal shipment of medical cannabis into the EU from North America, which marks an important milestone in the global progres

Herbal Cures / If Your Are Serious Enough You Will Cure Barreness
« on: May 11, 2019, 07:08:40 AM »
Do you have strong infection or trying to get pregnant ? Read carefully :


Combo means combination and it is the mixture of herbs like Turmeric (Tale pupa), Ginger, Garlic and Clove (zobo pepper) to solve one or two issues in our body....

1. It works for infections especially long time infections.
2. Weight reduction especially the tommy areas.
3. Cycle correction especially scanty and ceased period.
4. Sex and libido booster.

Peel off the back of the Ginger, Garlic and Turmeric. Cut them into small sizes and wash with clean water. Then soak all the ingredients in a container like eva water add the cloves, Let it stay for 3days.

Take half a glass first thing in the morning before meals and last thing at night before going to bed.

Turmeric #100
Cloves #50
Ginger #50
Garlic #50
Booni #50
Water 75cl eva water
Note: All your ingredients should be fresh

Take combo for one week and observe your system, if you are not satisfied, soak another portion and take for another 7days and stop.

1. For trying to conceive mothers, take during your period.
2. When you are not on drugs or other medications.

1. Male and female
2. Children above the ages of 16
3. For children below 16, dilute the combo with water twice as you would add water when preparing for adult, give them two teaspoons.
4. Singles
5. TTC mothers (Trying to conceive).
6. Couples wanting to boost their sexual libido.

Do not take during your ovulation period or most fertile period.

1. Pregnant women
2. Nursing mothers
3. Ulcer patient

4. Honda Civic Sedan 1.5T (Tie)
32 City / 42 Highway / 36 Combined

Honda has two of the most fuel-efficient cars in America on this list: the Fit, and the turbocharged Civic sedan. With the smaller 1.5-liter engine and a continuously variable transmission, the Civic gets 32 miles per gallon in the city, 42 on the highway, and 36 combined. Owners should expect to pay an annual fuel cost of $1,050.

3. Toyota Corolla Hatchback (Tie)
32 City / 42 Highway / 36 Combined

The Toyota Corolla Hatchback boots the iM five-door from the Toyota lineup (though, the Yaris still exists). And with 32 miles per gallon city, 42 highway, and 36 combined, it's more efficient than its outdated sibling. The 2.0-liter four-cylinder engine with a continuously variable transmission produces 168 horsepower (125 kilowatts), and costs owners an average of $1,050 in fuel per year.

2. Chevrolet Cruze Diesel Sedan
31 City / 48 Highway / 37 Combined

Though the diesel Cruze is dying in North America, Chevy isn't pulling the metaphorical plug on it in other markets just yet. For 2019, both the diesel sedan and hatchback soldier on in the States. The former four-door option is the second most fuel-efficient non-hybrid in the U.S. right now, with 31 miles per gallon in the city, 48 on the highway, and 37 combined. The 1.6-liter four-cylinder diesel engine produces 137 horsepower (102 kilowatts), and annual fuel costs are an estimated $1,250.

1. Mitsubishi Mirage
36 City / 43 Highway / 39 Combined

The cheapest car of 2019 is also the most fuel efficient. Even with relatively recent updates, the Mitsubishi Mirage maintains its 36 miles per gallon city, 43 highway, and 39 combined rating, beating the next-best Chevy Cruze Diesel by a modest two MPG overall. With its tiny 1.3-liter engine, just 78 horsepower (58 kilowatts), and a continuously variable transmission, Mirage owners spend an average of $950 per year on fuel.

10. Kia Forte FE
31 City / 41 Highway / 35 Combined

Redesigned and reimagined for 2019, the Kia Forte cracks the top 10 with its most-efficient FE model. The 2.0-liter inline-four engine underhood produces 147 horsepower (109 kilowatts), and helps return fuel economy of 31 miles per gallon in the city, 41 highway, and 35 combined. Annual fuel costs are a mere $1,050, according to the EPA.

9. Jaguar XF Diesel
31 City / 42 Highway / 35 Combined

Jaguar's large and lovely XF isn't usually known for its efficiency – unless we're talking about the 35 mile-per-gallon combined diesel model. The turbocharged 2.0-liter engine produces 180 horsepower (134 kilowatts) and helps return 31 miles per gallon in the city and 42 on the highway. Annual fuel costs are a bit higher at $1,300, due in part to the price of diesel.
Check Out These Other Lists:

  Do It For The Gram: 15 Most Popular Cars And Trucks On Instagram
  10 Reasons To Buy An Electric Vehicle In 2019
  25 Future Supercars And Sports Cars Worth Waiting For
  2019 Midsize Pickup Truck Comparison: How Do They Stack Up?

7. Hyundai Elantra Eco (Tie)

32 City / 40 Highway / 35 Combined

The whole updated Hyundai Elantra range ranks near the top of the class in terms of efficiency. But it's the 1.5-liter-powered Elantra Eco (note: Elantra Limited pictured) that gets the highest marks, returning 32 miles per gallon in the city, 40 on the highway, and 35 combined. Owners can expect to pay $1,050 in fuel costs per year.
Check Out These Other Lists:

  Do It For The Gram: 15 Most Popular Cars And Trucks On Instagram
  10 Reasons To Buy An Electric Vehicle In 2019
  25 Future Supercars And Sports Cars Worth Waiting For
  2019 Midsize Pickup Truck Comparison: How Do They Stack Up?

7. Toyota Yaris Sedan (Tie)

32 City / 40 Highway / 35 Combined

The Mazda-based, Scion-faced Toyota Yaris sedan doesn't look much like the rest of the lineup, but its efficiency stays the course with other Toyota products (some you'll see later on this list). The 1.5-liter four-cylinder produces a mere 106 horsepower (79 kilowatts) but helps return 32 miles per gallon in the city, 40 highway, and 35 combined. Annual fuel should set owners back about $1,050.

da Fit
33 City / 40 Highway / 36 Combined

The current Honda Fit has been around for a minute, but even in old age, it's still one of the most efficient cars in America. With its 1.5-liter four-cylinder engine, the Fit gets 33 miles per gallon in the city, 40 highway, and 36 combined. Owners should expect to pay an annual fuel cost of $1,050.

5. Jaguar XE Diesel
32 City / 42 Highway / 36 Combined

Believe it, the Jaguar XE Diesel is the third-most fuel-efficient car in the U.S. in 2019. Granted, it's a trim of a sedan that typically isn't near the top of any fuel efficiency lists, but it's a Jag nonetheless. The XE diesel, powered by a 2.0-liter four-cylinder producing 180 horsepower (134 kilowatts), gets up to 36 miles per gallon combined – which rivals the next two cars on this list. But it owners an average of $1,300 per year in fuel.

Career / Re: 5 Questions That Will Help You Choose the Best Career
« on: May 07, 2019, 04:44:04 AM »
This is another place where the data can be extremely helpful. If location is important to you, head to the Bureau of Labor Statistics‘ website and do a few searches of job titles by region.

Deciding which career is right for you can be an overwhelming process. Rather than focusing on identifying a direct path, first determine your own needs and goals, and then sync your findings with what the world has to offer.

Career / Re: 5 Questions That Will Help You Choose the Best Career
« on: May 07, 2019, 04:43:16 AM »
Promotion-focused professionals are classic creatives and entrepreneurs. They work quickly, seize new opportunities and think abstractly. The downside is that they can be impulsive, overly optimistic and are likely to make bigger mistakes.

Prevention-focused professionals are just the opposite, focused on maintaining the status quo and protecting all they’ve worked on. These professionals prefer planning, reliability, thoroughness and analytical thinking.

While we all need a little bit of promotion- and prevention-oriented thinking, it’s important to determine which way you lean before diving down a career path. A prevention-focused person, for example, would do far better as a developer in a major corporation than launching her own startup. A promotion-oriented person will likely feel suffocated in a traditional 9-to-5, thriving instead in a more creative environment with bigger risks and bigger rewards.

3. What is the best environment for your personality type?

For similar reasons, it’s often helpful to do even deeper personality tests like the Myers-Briggs. This will help you further pinpoint just what you need in your work environment to thrive. Particularly important is determining whether you’re more of an introvert or an extrovert, as the two personality types differ widely in their needs.

An introvert, for example, may be more attracted to a quieter research role, while an extrovert will thrive in a busy, loud sales office. Public speaking, amount of teamwork required and frequent contact with clients are also factors to consider.

But as Susan Cain articulates so well in her book Quiet: The Power of Introverts in a World That Can’t Stop Talking, introverts and extroverts can both thrive in roles better suited for the opposite personality type, as long as they’re passionate about the cause or are able to adapt the job to fit their style. This is why stopping to think out your passions is important, though you’ll also discover many along the way.

4. What kind of lifestyle do you want?

Most jobs start off with at least a few years of hard labor at lower pay than you’d like. What’s more important is looking ahead at people well into a career track to determine whether the lifestyle they lead is desirable to you. Some factors you might want to consider include the amount of control they have over their own time, their salary and the amount of travel involved, among other factors.

I’m not saying you need to have a distinct goal like “$150,000 per year or bust.” I’m saying that what’s acceptable to you is highly individual, and it’s important to do what will make you the most comfortable.

If giving back to the community gives you the most job satisfaction, then perhaps being a social worker with a relatively low wage will satisfy your needs. But if you’d prefer to turn off work at the end of the day and go live your “real” life, including eating out, travel and play, then perhaps a higher salary goal is more appropriate.

Again, these are things you may discover as you go.

5. Where do you want to live?

While not essential for every career type, determining where you want to live can be an important part of the career search process. This is especially true for jobs that are focused in certain regions. If you want to work in the magazine industry, then you’ll probably need to move to New York City. Wheat farmer? The Midwest. Anthropologist? Just about anywhere.

Beyond geographical region, think again about the lifestyle on offer in the places you’ll be headed. Do you seek a metropolitan lifestyle with restaurants and cultural attractions on every corner? Or do you need the beauty and quiet of a rural setting?

This is another place where the data can be extremely helpful. If location is important to you, head to the Bureau of Labor Statistics‘ website and do a few searches of job titles by region.

Career / 5 Questions That Will Help You Choose the Best Career
« on: May 07, 2019, 04:41:41 AM »
Too many choices are not always good, especially when it comes to picking your career. Use these soul-searching questions to decide which path is right for you.

Take a look at most LinkedIn profiles, and it’s clear that the traditional three-step career plan (graduate college, get a job, work your way up the ladder for the next 40 years at the same company) is outdated. Today’s professionals swap job titles like kids trading snacks at the lunch table, toggling between many companies, teams and industries throughout the course of their careers.

The upside to this trend is that as a young professional, you’ll have a lot of choice throughout your career. The downside is that not all choices are necessarily good, and having too many can be paralyzing.

To aid in the often overwhelming process of choosing a career, my team at Distilled and I worked alongside Rasmussen College to create an interactive career choice tool. Drawing from Bureau of Labor Statistics data, this visualization compares median salary and number of people employed across various fields and job titles. You can narrow your options by choosing what career fields interest you. Clicking on a single dot loads extended information about that job, including a short description of the role, projected growth by 2020 and the level of education needed to obtain that job.

Why put all this data in one place?

Because mapping the number of job opportunities in a given field vs. potential salaries vs. the stability of the market for the next few years can ensure you’re investing in a career that won’t dead-end. As the labor market continues to shift due to changes in technology and the economy, choosing the right path from the beginning can help you avoid emotional and financial stress down the road.

Of course, you should consider other factors when trying to decide which career to pursue. The above interactive tool is but one piece of the puzzle; it’s best used as a foundation as you ask yourself other crucial questions and try to answer the age-old question, “Which career is right for me?”

Here are a few great questions to ask as you decide:

1. What are you good at, and what do you love?

Yeah, I know. You’ve heard the “follow your passion” line since the day you were born. While some people have a clear passion, many of us find ourselves lost in the “passion puzzle,” paralyzed with fear that we’re not doing it right if we don’t have one burning career goal to pursue obsessively. And even if you do have a passion, chances are high it’s something vague and out of reach, like becoming the next Stephen King.

The problem isn’t the idea of pursuing things you’re good at and that you love; it’s that your aspirations are too broad and difficult to act on. Think of your passions as a starting point. If you want to be the next Stephen King, break that passion down into writing and editing. Then do a “skills inventory” to determine just what else you bring to the table.

Are you good at providing feedback and coaching other writers? Then becoming a writing teacher or tutor might be right for you. How about really digging into a subject, synthesizing a ton of research and guiding editorial direction? Then becoming a tech writer or editor might be a better fit.

Your skills inventory could take the form of a checklist, a mock resume or interviews with friends, family members, mentors and former employers who can provide an outside perspective. You can then return to a tool like the one provided above and more carefully match your skills and interests to job titles, narrowing in on those that are both best suited to you and have the best prospects for growth.

2. Are you promotion- or prevention-focused?
Feeling motivated is an essential aspect of job satisfaction. But causes for motivation vary widely from person to person. In general, there tend to be two main motivation types: promotion-focused and prevention-focused.

Pages: [1] 2 3 ... 5